Multiple system atrophy (MSA) is a progressive disorder with limited treatment options. However, recent research has yielded potential insights into new therapeutic approaches. Current focus centers on modifying the underlying causes of MSA. One approach under investigation involves drug-based interventions to regulate the function of specific neu